CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.010
-0.040 (-3.81%)
At close: Mar 9, 2026, 4:00 PM EDT
1.060
+0.050 (4.95%)
After-hours: Mar 9, 2026, 4:00 PM EDT
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $11.66 million as of March 9, 2026. Its market cap has decreased by -63.27% in one year.
Market Cap
11.66M
Enterprise Value
10.26M
1-Year Change
-63.27%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $11.66M, a decrease of -74.73%. That is a compound annual growth rate of -37.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 12.12M | -21.35% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 12.79M |
| BioLineRx | 12.68M |
| NewcelX | 12.63M |
| BioCardia | 12.52M |
| Phio Pharmaceuticals | 12.49M |
| BioAtla | 12.46M |
| Soligenix | 12.00M |
| Cellectar Biosciences | 11.70M |